The American Journal of Surgery
Volume 198, Issue 1 , Pages 39-45 , July 2009

Risk factors and outcome of early recurrence after resection of small hepatocellular carcinomas

Received 8 February 2008 ,Revised 11 July 2008

References 

  1. Bosch X, Ribes J, Borras J. Epidemiology of primary liver cancer. Semin Liver Dis. 1999;19:271–285
  2. Taylor-Robinson SD, Foster GR, Arora S, et al. Increase in primary liver cancer in the UK 1979–94. Lancet. 1997;350:1142–1143
  3. EI-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 1999;340:745–750
  4. Arii S, Yamaoka Y, Futagawa S, et al. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinoma: a retrospective and nationwide survey in Japan. J Hepatol. 2000;32:1224–1229
  5. Kotoh K, Sakai H, Sakamoto S, et al. The effect of percutaneous ethanol injection therapy on small solitary hepatocellular carcinoma is comparable to that of hepatectomy. Am J Gastroenterol. 1994;89:194–198
  6. Seki T, Wakabayashi M, Nakagawa T, et al. Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma. Cancer. 1994;74:817–825
  7. Chen MS, Li JO, Zheng Y, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg. 2006;243:321–328
  8. Regimbeau JM, Abdalla EK, Vauthey JN, et al. Risk factors for early death due to recurrence after liver resection for hepatocellular carcinoma: results of a multicenter study. J Surg Oncol. 2004;58:36–41
  9. Shimada M, Takenaka K, Gion T, et al. Prognosis of recurrent hepatocellular carcinoma: a 10-year surgical experience in Japan. Gastroenterology. 1996;111:720–726
  10. Poon RTP, Fan ST, Lo CM, et al. Intrahepatic recurrence after curative resection for hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg. 1999;229:216–222
  11. Ikeda Y, Kajiyama K, Adachi E, et al. Early recurrence after surgery of hepatocellular carcinoma. Hepatogastroenterology. 1995;42:469–472
  12. Nagao T, Inoue S, Yoshimi F, et al. Postoperative recurrence of hepatocellular carcinoma. Ann Surg. 1990;211:28–33
  13. Shirabe K, Kanematsu T, Matsumata T, et al. Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: univariate and multivariate analyses. J Hepatol. 1991;14:802–805
  14. Poon RT, Fan ST, Ng IO, et al. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer. 2000;89:500–507
  15. Peng SY, Chen WJ, Lai PL, et al. High α-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and β-catenin mutations. Int J Cancer. 2004;112:44–50
  16. Kwon AH, Ha-Kawa SK, Uetsuji S, et al. Preoperative determination of the surgical procedure for hepatectomy using technetium-99m-galactosyl human serum albumin (99mTc-GSA) liver scintigraphy. J Hepatol. 1997;25:426–429
  17. Kaibori M, Matsui Y, Hijikawa T, et al. Comparison of limited and anatomic hepatic resection for hepatocellular carcinoma with hepatitis C. Surgery. 2006;139:385–394
  18. Makuuchi M, Kosuge T, Takayama T, et al. Surgery for small liver cancers. Semin Surg Oncol. 1993;9:298–304
  19. Couinaud C. Les hepatectomies elargies. In:  Couinaud C editors. Le Foie: Etudes Anatomiques et Chirurgicales. Paris: Masson; 1957;p. 400–409
  20. Sobin LH, Wittekind C. TNM Classification of Malignant Tumours. 6th ed.. New York: Wiley; 2002;
  21. Lau WY. Management of hepatocellular carcinoma. J R Coll Surg Edinb. 2002;47:389–399
  22. Lau WY, Leung TW, Yu SC, et al. Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future. Ann Surg. 2003;237:171–179
  23. Castells A, Bruix J, Bru C, et al. Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection. J Hepatol. 1993;18:1121–1126
  24. Livraghi T, Bolondi L, Lazzaroni S, et al. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis: a study on 207 patients. Cancer. 1992;69:925–929
  25. Rossi S, Buscarini E, Garbagnati F, et al. Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode. AJR Am J Roentgenol. 1998;170:1015–1022
  26. Buscarini L, Buscarini E, Di Stasi M, et al. Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results. Eur Radiol. 2001;11:914–921
  27. Yamamoto M, Takasaki K, Otsubo T, et al. Favorable surgical outcomes in patients with early hepatocellular carcinoma. Ann Surg. 2004;239:395–399
  28. Nakashima O, Sugihara S, Kaga M, et al. Pathomorphologic characteristics of small hepatocellular carcinoma: a special reference to small hepatocellular carcinoma with indistinct margins. J Hepatol. 1995;22:101–105
  29. Rim KS, Sakamoto M, Watanabe H, et al. Pathology and DNA cytophotometry of small hepatocellular carcinoma with a nodule-in-nodule appearance—evidence for stepwise progression of hepatocellular carcinoma. Jpn J Clin Oncol. 1993;23:26–33
  30. Degos F, Christidis C, Ganne-Carrie N, et al. Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death. Gut. 2000;47:131–136
  31. Khan MH, Farrell GC, Byth K, et al. Which patients with hepatitis C develop liver complications?. J Hepatol. 2000;31:513–520
  32. Hu KQ, Tong MJ. The long-term outcomes of patients with compensated hepatitis C virus-related cirrhosis and history of parenteral exposure in the United States. J Hepatol. 1999;29:1311–1316
  33. Yamamoto J, Kosuge T, Takayama T, et al. Recurrence of hepatocellular carcinoma after surgery. Br J Surg. 1996;83:1219–1222
  34. Nagasue N, Uchida M, Makino Y, et al. Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology. 1993;105:488–494
  35. Sasaki Y, Imaoka S, Matsutani S, et al. Influence of coexisting cirrhosis on long-term prognosis after surgery in patients with hepatocellular carcinoma. Surgery. 1992;112:515–521
  36. Ng IOL, Lai ECS, Fan ST, et al. Prognostic significance of pathologic features of hepatocellular carcinoma (A multivariate analysis of 278 patients). Cancer. 1995;76:2443–2448
  37. Meyer B, Luo HS, Bargetzi M, et al. Quantitation of intrinsic drug-metabolizing capacity in human liver biopsy specimens: support for the intact-hepatocyte theory. J Hepatol. 1991;13:475–481
  38. Ota T, Seki M, Morita RC. Report: focal fatty infiltration of the liver with accumulation defect on Tc-99m colloid and Tc-99m-GSA scintigraphy. Clin Radiol. 1997;52:399–401
  39. Tomiguchi S, Kira T, Oyama Y, et al. Correlation of Tc-99m GSA hepatic studies with biopsies in patients with chronic active hepatitis. Clin Nucl Med. 1995;20:717–720
  40. Yamanaka N, Okamoto E, Fujihara S, et al. Do the tumor cells of hepatocellular carcinomas dislodge into the portal venous stream during hepatic resection?. Cancer. 1992;70:2263–2267
  41. Ono T, Yamanoi A, Nazmy EI, et al. Adjuvant chemotherapy after resection of hepatocellular carcinoma causes deterioration of long-term prognosis in cirrhotic patients: meta-analysis of three randomized controlled trials. Cancer. 2001;91:2378–2385
  42. Lai EC, Lo CM, Fan ST, et al. Postoperative adjuvant chemotherapy after curative resection of hepatocellular carcinoma: a randomized controlled trial. Arch Surg. 1998;133:183–188
  43. Yamamoto M, Arii S, Sugahara K, et al. Adjuvant oral chemotherapy to prevent recurrence after curative resection for hepatocellular carcinoma. Br J Surg. 1996;83:336–340
  44. Hemming AW, Cattral MS, Reed AI, et al. Liver transplantation for hepatocellular carcinoma. Ann Surg. 2001;233:652–659

PII: S0002-9610(08)00737-X

doi: 10.1016/j.amjsurg.2008.07.051

The American Journal of Surgery
Volume 198, Issue 1 , Pages 39-45 , July 2009

Article Tools

* Image Usage & Resolution